Screener
Aclaris Therapeutics ACRS Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$21.51M-39.4% | -$19.82M-31.4% | -$19.8M+79.5% | -$14.61M-92.6% | -$15.43M-40.4% | ||
| $107K-6.1% | $102K-20.3% | $102K-28.7% | $110K-38.5% | $114K-52.9% | ||
| $2.67M-12.8% | $3.2M-9.5% | $2.93M+2.3% | $2.86M-4.8% | $3.06M+5.5% | ||
| -$19.85M-98.6% | -$18.15M-39.0% | -$13.13M-46.9% | -$10.93M— | -$9.99M+18.9% | ||
| $58K+176% | $13K-69.8% | $24K— | $23K— | $21K— | ||
| —— | -$30.93M-262% | $10.37M+112% | $13.83M+395% | $5.05M+849% | ||
| $91K+1,111% | $57.78M+21,111% | -$2.53M-103% | -$3.04M-13,936% | -$9K+18.2% | ||
| -$9.49M— | $8.7M+50.3% | -$5.3M+77.1% | —— | —— | ||
| -$19.91M-98.8% | -$18.16M-38.6% | -$13.16M-47.2% | -$10.96M— | -$10.01M+18.6% |
FAQ
- How much cash does Aclaris Therapeutics generate?
- Aclaris Therapeutics (ACRS) generated -$62.1M in operating cash flow over the trailing twelve months.
- What is Aclaris Therapeutics's free cash flow?
- After $118.0K of capital expenditures, Aclaris Therapeutics's free cash flow was -$62.2M over the trailing twelve months, down 40.2% year over year.
- Where does Aclaris Therapeutics's cash flow data come from?
- Every line is extracted from Aclaris Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
